DrugMap Central: an on-line query and visualization tool to facilitate drug repositioning studies
- PMID: 23681121
- PMCID: PMC3702253
- DOI: 10.1093/bioinformatics/btt279
DrugMap Central: an on-line query and visualization tool to facilitate drug repositioning studies
Abstract
Summary: Systematic studies of drug repositioning require the integration of multi-level drug data, including basic chemical information (such as SMILES), drug targets, target-related signaling pathways, clinical trial information and Food and Drug Administration (FDA)-approval information, to predict new potential indications of existing drugs. Currently available databases, however, lack query support for multi-level drug information and thus are not designed to support drug repositioning studies. DrugMap Central (DMC), an online tool, is developed to help fill the gap. DMC enables the users to integrate, query, visualize, interrogate, and download multi-level data of known drugs or compounds quickly for drug repositioning studies all within one system.
Availability: DMC is accessible at http://r2d2drug.org/DMC.aspx.
Contact: STWong@tmhs.org.
Figures
Similar articles
-
EK-DRD: A Comprehensive Database for Drug Repositioning Inspired by Experimental Knowledge.J Chem Inf Model. 2019 Sep 23;59(9):3619-3624. doi: 10.1021/acs.jcim.9b00365. Epub 2019 Sep 3. J Chem Inf Model. 2019. PMID: 31433187
-
DrugMAP 2.0: molecular atlas and pharma-information of all drugs.Nucleic Acids Res. 2025 Jan 6;53(D1):D1372-D1382. doi: 10.1093/nar/gkae791. Nucleic Acids Res. 2025. PMID: 39271119 Free PMC article.
-
In silico drug repositioning: from large-scale transcriptome data to therapeutics.Arch Pharm Res. 2019 Oct;42(10):879-889. doi: 10.1007/s12272-019-01176-3. Epub 2019 Sep 3. Arch Pharm Res. 2019. PMID: 31482491 Review.
-
TarPred: a web application for predicting therapeutic and side effect targets of chemical compounds.Bioinformatics. 2015 Jun 15;31(12):2049-51. doi: 10.1093/bioinformatics/btv099. Epub 2015 Feb 16. Bioinformatics. 2015. PMID: 25686637
-
Computational and experimental advances in drug repositioning for accelerated therapeutic stratification.Curr Top Med Chem. 2015;15(1):5-20. doi: 10.2174/1568026615666150112103510. Curr Top Med Chem. 2015. PMID: 25579574 Review.
Cited by
-
Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.Am J Physiol Cell Physiol. 2015 Oct 1;309(7):C444-56. doi: 10.1152/ajpcell.00188.2015. Epub 2015 Jul 29. Am J Physiol Cell Physiol. 2015. PMID: 26224579 Free PMC article. Review.
-
Review of Drug Repositioning Approaches and Resources.Int J Biol Sci. 2018 Jul 13;14(10):1232-1244. doi: 10.7150/ijbs.24612. eCollection 2018. Int J Biol Sci. 2018. PMID: 30123072 Free PMC article. Review.
-
Repurposing Zileuton as a Depression Drug Using an AI and In Vitro Approach.Molecules. 2020 May 5;25(9):2155. doi: 10.3390/molecules25092155. Molecules. 2020. PMID: 32380663 Free PMC article.
-
Novel modeling of cancer cell signaling pathways enables systematic drug repositioning for distinct breast cancer metastases.Cancer Res. 2013 Oct 15;73(20):6149-63. doi: 10.1158/0008-5472.CAN-12-4617. Epub 2013 Oct 4. Cancer Res. 2013. PMID: 24097821 Free PMC article.
-
Proceedings of the 12th Annual UT-ORNL-KBRIN Bioinformatics Summit 2013.BMC Bioinformatics. 2013 Mar 22;14 Suppl 17(Suppl 17):A1. doi: 10.1186/1471-2105-14-s17-a1. BMC Bioinformatics. 2013. PMID: 24625056 Free PMC article. No abstract available.
References
-
- Ashburn TT, Thor KB. Drug repositioning: identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov. 2004;3:673–683. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous